全球口腔癌治疗市场 – 行业趋势及 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球口腔癌治疗市场 – 行业趋势及 2030 年预测

  • Pharmaceutical
  • Upcoming Report
  • Apr 2023
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Oral Cancer Treatment Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 1,805.80 Billion
Diagram Market Size (Forecast Year)
USD 2,729.72 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>全球口腔癌治疗市场,按类型(口腔鳞状细胞癌、口腔疣状癌、粘液表皮样癌和口腔淋巴瘤)、治疗类型(化疗、放射疗法和生物疗法)、治疗(药物和手术)、给药途径(口服、注射和其他)、最终用户(医院、家庭护理、专科诊所和其他)、分销渠道(医院药房、零售药房和其他)划分 - 行业趋势和预测到 2030 年。

口腔癌治疗市场

口腔癌治疗市场分析及规模

口腔癌是全球面临的严重问题。据口腔癌基金会统计,美国每年约有 53,000 例新口腔癌病例被诊断出来,超过 9,750 人患有此病。如此高的患病率要求更高的治疗需求。牙科技术的发展有望为公司带来丰厚的增长前景。

Data Bridge Market Research 分析,口腔癌治疗市场规模将从 2022 年的 18.058 亿美元增至 2030 年的 27.2972 亿美元,预计在 2023 年至 2030 年的预测期内复合年增长率为 5.30%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

口腔癌治疗市场范围和细分

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021(可定制为 2015 - 2020)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

类型(口腔鳞状细胞癌、口腔疣状癌、粘液表皮样癌和口腔淋巴瘤)、治疗类型(化疗、放射治疗和生物治疗)、治疗(药物和手术)、给药途径(口服、注射和其他)、最终用户(医院、家庭护理、专科诊所和其他)、分销渠道(医院药房、零售药房和其他)

覆盖国家

北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、欧洲的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区

涵盖的市场参与者

Bayer AG (Germany), Aurobindo Pharma (India), AbbVie Inc. (U.S.), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Bausch Health Companies Inc. (U.S.), Accord Healthcare (U.K.), Genentech, Inc (U.S.)., Bristol-Myers Squibb Company (U.S.), GSK plc (U.K.), Ascendis Pharma A/S (Denmark), Sanofi (France), Pfizer Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India)

Market Opportunities

  • Growing Elderly Population
  • Increasing Healthcare Expenditure

Market Definition

Oral cancer is a type wherein the malignant tumor develops in the tissues in the mouth and around the throat. It is also known as mouth cancer. The common symptoms associated with it are white patches and ulcers. Oral cancers are either benign or malignant. Furthermore, surgical removal of benign tumors is possible with regard to its treatment.

Global Oral Cancer Treatment Market Dynamics

Drivers

  • Increasing Prevalence of Oral Cancer

The increasing prevalence of oral cancer is increasing the market growth demand. As per the American Cancer Society, oral and oropharyngeal cancer prevalence has been growing in recent years. This increasing elderly population has higher chances of oral cancer, which grows the market. In 2021, around 54,010 people in the U.S. were diagnosed with oral cavity or oropharyngeal cancer, and around 10,850 died for the same.  As per the National Cancer Institute, in the U.S. in 2021, there were approximately 53,260 new oral and oropharyngeal cancer cases and an estimated 10,750 deaths from these cancers. This increasing prevalence demands the high treatment processes of oral cancer, which further leads to market growth. Thus, this factor leads to the growth of the market.

Opportunities

  • Growing Elderly Population

Increasing rate of elderly population leads to market growth. For instance, a lack of poor oral health and a switch from complex to simple carbohydrates let the elderly at risk for developing root caries. Over 50% of people aged 75 years and above have at least one tooth affected by root caries which further causes little damage can weaken the entire tooth leading to the severe infection. Thus, this factor boosts market growth.  

  • Increasing Healthcare Expenditure

Dental technology developments are expected to provide companies with huge growth prospects. For instance, Pearl raised US$ 11 million in May 2019 to use AI to measure dental scans. As per the company, it will ease the tedious, repetitive operations, boost profits across dentistry, and—most notably improve the level of care. Thus, this factor serves as a major factor that increases market growth.

Restraints/Challenges

  • High Cost of Oral Cancer Treatment

The huge cost of treatment and diagnostic procedures related to oral cancer hinders the market. Numerous procedures are costly and cannot be afforded by underdeveloped and developing countries. Thus, this factor impedes market growth.  

  • Side Effects of Oral Cancer Treatment

There are huge side effects associated with oral cancer treatment. There are several severe side effects that may arise if the dosage is high such as hair loss, mouth sores, loss of appetite or weight loss, nausea and vomiting which restricts the patient from adopting the treatment for a long time. Thus, this factor impedes the market growth.

This oral cancer treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the oral cancer treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In 2022, ZimVie Inc. launched TSX Implant in the U.S., the latest innovation in the company's surgical, restorative, and digital dentistry solutions platform. TSX Implants are designed for instant extraction and loading protocols, placement predictability, and primary stability in soft and dense bone.

Global Oral Cancer Treatment Market Scope

The oral cancer treatment market is segmented on the basis of type, therapy type, treatment, route of administration, end users, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Oral Squamous Cell Carcinoma
  • Oral Verrucous Carcinoma
  •  Mucoepidermoid Carcinoma
  • Oral Cavity Lymphomas

Therapy Type

  • Chemotherapy
  • Radiation Therapy
  • Biological Therapy

Treatment

  • Medication
  • Cisplatin
  • Docetaxel
  • Methotrexate
  • Bleomycin Sulfate
  • Pembrolizumab
  • Surgery
  • Laryngectomy
  • Glossectomy
  • Others

Route of Administration

  • Oral
  • Injectable
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  •  Others

Oral Cancer Treatment Market Regional Analysis/Insights

The oral cancer treatment market is analyzed and market size insights and trends are provided by type, therapy type, treatment, route of administration, end users, and distribution channel as referenced above.

The countries covered in the oral cancer treatment market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific is expected to grow during the forecast period because of the increasing expenditure to develop healthcare infrastructure and growing tobacco consumption. The market growth is also enhanced by the launch of products in the region.

North America dominates the market in the forecast to the rising affordability of drugs and the surge in the cases of oral cancer. Furthermore, growing awareness among the people in this region to cure dental caries and technological developments because of the presence of major market players lead to market growth.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The oral cancer treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for oral cancer treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the oral cancer treatment market. The data is available for historic period 2011-2021.

Competitive Landscape and Oral Cancer Treatment Market Share Analysis

The oral cancer treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to oral cancer treatment market.

口腔癌治疗市场的一些主要参与者包括:

  • 拜耳公司(德国)
  • Aurobindo Pharma(印度)
  • AbbVie Inc.(美国)
  • 诺华公司(瑞士)
  • F. Hoffmann-La Roche Ltd(瑞士)
  • Bausch Health Companies Inc.(美国)
  • Accord Healthcare(英国)
  • 基因泰克公司(美国)
  •  百时美施贵宝公司 (美国)
  • 葛兰素史克公司 (英国)
  • Ascendis Pharma A/S(丹麦)
  • 赛诺菲(法国)
  • 辉瑞公司(美国)
  • 太阳制药工业有限公司 (印度)
  • 鲁冰花(印度)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Oral Cancer Treatment Market is projected to grow at a CAGR of 5.30% during the forecast period by 2030.
The future market value of the Oral Cancer Treatment Market is expected to reach USD 2,729.72 million by 2030.
The major players in the Oral Cancer Treatment Market are Bayer AG (Germany), Aurobindo Pharma (India), AbbVie Inc. (U.S.), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Bausch Health Companies Inc. (U.S.), Accord Healthcare (U.K.), etc.
The countries covered in the Oral Cancer Treatment Market are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, etc.